Product Images Gabapentin

Gabapentin is a capsule with a strength of 300 mg, available through a prescription. It is manufactured by Ascend Labs, located in Montvale, New Jersey with Source NDC of 67877-0223-05. The medication is to be kept out of reach of children, and the patient should consult the package insert before use. The medication should be stored at a temperature between 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) [See USP]. The Repackaging is done by RemedyRepack Inc., located in Indiana, PA 15701, and their phone number is 724.466.8762.*

Gabapentin is a medication that comes in 300 mg capsules. This prescription item has an NDC number of 70518-3329-02 and should be stored at a temperature range of 20-26°C (63-77°F), with excursions allowed between 15-30°C (59-86°F) as stated by USP standards. It is manufactured by Ascend Labs, LLC, Montvale, NJ 07645 and contains specific usage instructions which can be located in the package insert. This medication should be kept away from children. Additionally, this particular product was repackaged by RemedyRepack Inc., Indiana, PA 15701.*

Gabapentin is a medication that comes in capsules of 300mg and is sold in a bottle containing 100 capsules. This medication requires a prescription and is manufactured by Ascend Labs LLC located in Montvale, NJ. The NDC number for this product is 70518-3329-00 and the lot number and expiration date were left blank. The package insert should be read for specific directions on how to use Gabapentin. It is important to keep this medication out of the reach of children and store it between 20-26°C (63-77°F), with excursions permitted between 15-30°C (59-86°F) according to USP standards. This batch was repackaged by RemedyRepack Inc., headquartered in Indiana, PA.*

This appears to be a graph or chart showing the mean pain score for a study that involved a 4-week dose titration period and a 4-week fixed dose period. The study compared the effectiveness of a placebo to a high dose of gabapentin (3600 mg/day) in reducing pain. The baseline pain score is not specified.*

This is a chart displaying mean pain score results for different treatment periods using Gabapentin at doses of 1800 mg/day and 2400mg/day versus placebo. The chart shows a titration period followed by a fixed dose period. The baseline results are also shown. There is no additional information available in the text for further interpretation.*

The text seems to be a figure or table, showing the proportion of responders in a study about pain management. It includes percentages ranging from 100% to 10%. The study is related to PHN (Postherpetic neuralgia). The table also refers to different treatments (GBP 3600, PBO, GEBP 1800, and GBP 2400), but it is not clear how they are related to the percentages. There is also some notation about statistical significance (#p<00l, <0.001).*